Infanrix hexa™
111157
Phase 3 mab completed
Quick answer
Infanrix hexa™ for Poliomyelitis is a Phase 3 program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Poliomyelitis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed